Recombinant human erythropoietin therapy after allogeneic hematopoietic cell transplantation with a nonmyeloablative conditioning regimen: low donor chimerism predicts for poor response.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples